KRAS Kickers

4.2K posts

KRAS Kickers banner
KRAS Kickers

KRAS Kickers

@KRASKickers

#KRAS 🎯cancer patient group for reliable Knowledge Research Advocacy & Survivorship. Survival of the strategic. #KickCancersKRAS - 🚫 #KRASholes

International, ALL RAS cancers 参加日 Şubat 2020
4.8K フォロー中3.7K フォロワー
固定されたツイート
KRAS Kickers
KRAS Kickers@KRASKickers·
At @ASCO #GI26 we presented our KRAS KICKERS Trial Finder. Personalized: KRAS G12D, CRC, US trials Results (in 4 minutes): 20 trials go to KRASHUB.ORG in beta - would love your feedback abstract asco.org/abstracts-pres… FYI: G12V - 8 trials for CRC G12R - 7 trials for CRC
KRAS Kickers tweet mediaKRAS Kickers tweet mediaKRAS Kickers tweet mediaKRAS Kickers tweet media
English
1
1
3
1.1K
KRAS Kickers がリツイート
Isabel Preeshagul
Isabel Preeshagul@ipreeshagul·
What an impactful talk given by @KRASKickers @TerriConneran @cancerGRACE . She described her diagnosis as a “cancer circus “ not only Impacting her but her family and community. Her advice: - acknowledge - be present - safe words to Google - forgive self ❤️ you inspire me!
Isabel Preeshagul tweet media
English
0
4
1
81
KRAS Kickers がリツイート
Wungki Park, MD MS
Wungki Park, MD MS@CentralParkWMD·
#RAS #revolution in first line chemo combo with gemcitabine and nab-paclitaxel backbone, the preview for ongoing registrational RASolute 303 study #KRAS #PDAC @MSK_DeptOfMed @MSKCancerCenter
KRAS Kickers@KRASKickers

#KRASatAACR26 LB407 / 7 - Daraxonrasib plus chemotherapy (CT) as first-line (1L) treatment for patients (Pts) with metastatic pancreatic adenocarcinoma (mPDAC) April 21 MiniSymposium: Late-Breaking Research abstractsonline.com/pp8/?fbclid=Iw… @AACR @CentralParkWMD @aparna1024 #KRAS #AACR26

English
0
8
32
3.9K
KRAS Kickers がリツイート
Targeted Oncology
Targeted Oncology@TargetedOnc·
🔬 Phase 1 expansion shows Varseta-M delivers notable response rates and manageable safety in heavily pretreated metastatic #ColorectalCancer, with FDA registrational planning underway. hubs.li/Q047jfhC0
English
0
1
1
207
KRAS Kickers がリツイート
Alvaro Curiel-García, PhD
Alvaro Curiel-García, PhD@AlvaroCurielGa1·
Less than 2 months to @AACR! Thrilled to speak in the Major Symposium:RAS Inhibitors,Mechanisms of Resistance, & Drug Combinations. Grateful to the NextGen Stars Program for this opportunity. Looking forward to great science, connect with people & new collaborations. #AACR26
Alvaro Curiel-García, PhD tweet media
English
0
4
8
922
KRAS Kickers がリツイート
Young Lung Cancer Initiative
Young Lung Cancer Initiative@YoungLungCancer·
"I just sat there & I cried for a minute. But then I had to go home and tell my husband I had stage 4 lung cancer." At 33, Wyatt was diagnosed w Stage 4 lung cancer. He joins us to share his journey through 8 lines of treatment Episode 1: youtu.be/5Ura3M1b1HM?si…
YouTube video
YouTube
Young Lung Cancer Initiative tweet media
English
0
7
12
559
KRAS Kickers がリツイート
Yakup Ergün
Yakup Ergün@dr_yakupergun·
Next-generation KRAS G12C inhibitor olomorasib shows promising pan-tumor activity in a first-in-human study. ORR ~37% in non-CRC tumors with durable response. Activity even observed after prior KRAS G12C inhibitors. KRAS targeting keeps evolving. nature.com/articles/s4146…
Yakup Ergün tweet mediaYakup Ergün tweet media
English
1
33
98
7.2K
KRAS Kickers
KRAS Kickers@KRASKickers·
@dose_of_naz Recruiting at two sites: Puerto Rico & in Texas 234 international locatins listed.
English
0
0
1
9
KRAS Kickers
KRAS Kickers@KRASKickers·
new KRAS inhibitor trial A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation to open in April 2026 phase 1, 145 pts clinicaltrials.gov/study/NCT07458… "KST-6051 is a potent and selective inhibitor of KRAS, with balanced activity against KRAS in the active (GTP-bound) and inactive (GDP-bound) states..." kestreltherapeutics.com/patients/
KRAS Kickers tweet media
English
1
1
2
467